Davis B R, Sándor G K
Department of Oral and Maxillofacial Surgery, Queen Elizabeth Health Sciences Centre, Halifax, Nova Scotia.
J Otolaryngol. 1998 Apr;27(2):107-12.
To describe various applications of homologous fibrin glue in maxillofacial surgery. The clinical outcomes of the treated cases are discussed.
During the period January 1993 to July 1995, 71 patients underwent maxillofacial procedures in which homologous fibrin glue was utilized. The material used in each case was Tisseel, which is composed of human fibrinogen and bovine thrombin. The material was used to provide close and secure re-approximation of soft tissue in 20 patients requiring coronal flaps. Bone or alloplast fixation was undertaken with fibrin sealant in 14 patients. In 13 cleft lip and palate patients, the material was used in the repair of residual fistulas or clefts. Twelve patients had sinus lift procedures where the material fixated the bone graft and repaired the torn mucoperiosteal lining. Finally, 12 patients with coagulopathies had fibrin glue placed following exodontia. All patients were followed for a minimum of 6 months postoperatively.
Seventy patients treated with Tisseel had successful outcomes as determined by preoperative criteria. A single oral antral fistula recurred 3 weeks after surgery. No adverse reaction to the material was noted in any of the patients.
Homologous fibrin glue has various applications in the field of maxillofacial surgery and can be used with safe and predictable results.
描述同种异体纤维蛋白胶在颌面外科中的各种应用。并讨论治疗病例的临床结果。
在1993年1月至1995年7月期间,71例患者接受了使用同种异体纤维蛋白胶的颌面手术。每例使用的材料为Tisseel,它由人纤维蛋白原和牛凝血酶组成。该材料用于20例需要冠状皮瓣的患者,以实现软组织的紧密和牢固重新贴合。14例患者使用纤维蛋白密封剂进行骨或异体植入物固定。在13例唇腭裂患者中,该材料用于修复残留瘘管或裂隙。12例患者进行了鼻窦提升手术,该材料用于固定骨移植并修复撕裂的粘骨膜衬里。最后,12例凝血功能障碍患者在拔牙后使用了纤维蛋白胶。所有患者术后至少随访6个月。
根据术前标准,70例接受Tisseel治疗的患者取得了成功结果。1例口腔鼻窦瘘在术后3周复发。所有患者均未观察到对该材料的不良反应。
同种异体纤维蛋白胶在颌面外科领域有多种应用,使用安全且效果可预测。